Name: From Lab to Market: The Process of Commercializing Medical Technologies (en Inglés)
SKU: 56682305
Price: 470.79 MXN
Availability: InStock
Author: Walsh, Brian ; Plummer, D'Lynne ; Kingsley, Manuel
ISBN: 9781791382605

portada From Lab to Market: The Process of Commercializing Medical Technologies (en Inglés)

From Lab to Market: The Process of Commercializing Medical Technologies (en Inglés)

Formato

Libro Físico

Editorial

Independently Published

Autor

Walsh, Brian ; Plummer, D'Lynne ; Kingsley, Manuel

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

27.9x21.6x0.4 cm

Peso

0.23 kg.

ISBN13

9781791382605

Categorías

Empresa y gestión

From Lab to Market: The Process of Commercializing Medical Technologies (en Inglés)

Walsh, Brian ; Plummer, D'lynne ; Kingsley, Manuel (Autor) · Independently Published · Tapa Blanda

Libro Nuevo Importado

Envío: 17 a 22 días háb.

$ 1,046.20$ 470.79

-55%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan más de 100 unidades

$ 470.79

Llega entre el 29 Sep y el 07 Oct a CUAUHTÉMOC, Ciudad de México. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "From Lab to Market: The Process of Commercializing Medical Technologies (en Inglés)"

This guide is written for biomedical innovators seeking to improve the lives of patients bytranslating innovative technologies into medical technologies. The contents are focusedprimarily on business principles that have been distilled from hundreds of projects as part ofthe Coulter Foundation's Translational Partners Program and Coulter Translational RewardAwards. To date, the Foundation has funded more than 600 projects, which in the first 11 yearshave raised close to $6 billion in funding.The course Concept to Clinic: Commercializing Innovation (C3i), offered by the NationalInstitutes of Health (NIH), forms the basis of this Guide. This course has helped hundredsof university innovators, engineers, clinicians, and scientists learn how to commercialize thetechnologies they have developed in a very demanding market. The C3i program is basedon the Coulter commercialization process, an approach to biomedical research translationdeveloped and continuously refined by the Foundation in collaboration with its academicpartners across the country.